S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself

RWE Aktiengesellschaft Stock Price, News & Analysis (ETR:RWE)

€39.26
-0.30 (-0.76%)
(As of 11/29/2023 ET)
Compare
Today's Range
€39.16
€40.06
50-Day Range
€32.73
€39.56
52-Week Range
€31.55
€43.55
Volume
2.25 million shs
Average Volume
N/A
Market Capitalization
$29.20 billion
P/E Ratio
6.61
Dividend Yield
2.29%
Price Target
N/A

RWE stock logo

About RWE Aktiengesellschaft Stock (ETR:RWE)

RWE Aktiengesellschaft generates and supplies electricity from renewable and conventional sources primarily in Germany, the United Kingdom, Europe, North America, and internationally. It operates through five segments: Offshore Wind; Onshore Wind/Solar; Hydro/Biomass/Gas; Supply & Trading; and Coal/Nuclear. The company generates wind, hydro, solar, nuclear, gas, and biomass electricity. It also trades in energy commodities; and operates gas storage facilities, as well as battery storage activities. The company serves commercial, industrial, and corporate customers. RWE Aktiengesellschaft was founded in 1898 and is headquartered in Essen, Germany.

RWE Stock Price History

RWE Stock News Headlines

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Aktuelle Empfehlungen zur RWE Aktie
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Rwe Aktiengesellschaft (OTC: RWEOY)
350mw power station battery storage scheme hopes
RWE AG PK (RWEOY)
See More Headlines
Receive RWE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RWE Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Utilities - Diversified
Sub-Industry
N/A
Sector
Utilities
CIK
N/A
Fax
N/A
Employees
19,884
Year Founded
N/A

Profitability

Net Income
$4.42 billion
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$32.22 billion
Cash Flow
€10.40 per share
Book Value
€45.72 per share

Miscellaneous

Free Float
N/A
Market Cap
$29.20 billion
Optionable
Not Optionable
Beta
0.66
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Markus Krebber (Age 50)
    Chairman of the Executive Board & CEO
    Comp: $4.03M
  • Dr. Michael Muller (Age 52)
    CFO & Member of Executive Board
    Comp: $2.13M
  • Dr. Thomas Michel
    Chief Operating Officer
  • Ms. Katja Van Doren (Age 57)
    Member of the Executive Board, Chief Human Resources Officer (CHO) & Labour Director
  • Dr. Joachim Haaf
    Head of Group Insurance
  • Thomas Denny
    Head of Investor Relations
  • Dr. Ulrich Rust
    General Counsel
  • Ms. Stephanie Schunck
    Head of Group Communication and Public Affairs
  • Joachim Lochte
    Head of Corporate Responsibility & Environmental Protection
  • Mr. Paul van Son
    Chairman of Energy Projects - Middle East, North Africa & Turkey Region














RWE Stock Analysis - Frequently Asked Questions

How have RWE shares performed in 2023?

RWE Aktiengesellschaft's stock was trading at €41.59 at the beginning of the year. Since then, RWE stock has decreased by 5.6% and is now trading at €39.26.
View the best growth stocks for 2023 here
.

Is RWE Aktiengesellschaft a good dividend stock?

RWE Aktiengesellschaft (ETR:RWE) pays an annual dividend of €0.90 per share and currently has a dividend yield of 2.35%. The dividend payout ratio is 15.15%. This payout ratio is at a healthy, sustainable level, below 75%.

What other stocks do shareholders of RWE Aktiengesellschaft own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RWE Aktiengesellschaft investors own include Agilent Technologies (A), Alcoa (AA), Advance Auto Parts (AAP), Covestro (1COV), AbbVie (ABBV), Ambev (ABEV), Asbury Automotive Group (ABG), ABM Industries (ABM) and Abbott Laboratories (ABT).

This page (ETR:RWE) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -